Binding domains for blockers and substrates on the dopamine transporter in rat striatal membranes studied by protection against N-ethylmaleimide-induced reduction of [3H]WIN 35,428 binding

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 355, Issue 1, 1996, Pages 64-73

  Xu, Cen ^a   Coffey, Lori L ^b   Reith, Maarten E A ^b  

^a ILLINOIS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Dopamine transporter; N ethylmaleimide; Rat striatum; Sulfhydryl groups; WIN 35,428 binding

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; AMPHETAMINE; DOPAMINE TRANSPORTER; N ETHYLMALEIMIDE; THIOL GROUP;

ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; CORPUS STRIATUM; MALE; NONHUMAN; RAT;

EID: 0031022680     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00004919     Document Type: Article

References (61)

1. 3H]WIN 35,428 binding in the caudate nucleus of the rabbit: evidence for a single site on the dopamine transporter. J Pharmacol Exp Ther 273:435-444
2. Amara SG, Kuhar MJ (1993) Neurotransmitter transporters: recent progress. Annu Rev Neurosci 16:73-93
3. Baumann MH, Char GU, De Costa BR, Rice KC, Rothman RB (1994) GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat. J Pharmacol Exp Ther 271:1216-1222
4. Bonnet JJ, Costentin J (1986) GBR 12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo. Eur J Pharmacol 121:199-209
5. 3H]mazindol. J Pharmacol Exp Ther 253:1206-1214
6. Brocklehurst K (1979) The equilibrium assumption is valid for the kinetic treatment of most time-dependent protein-modification reactions. Biochem J 181:775-778
7. Calligaro DO, Eldefrawi ME (1987a) Central and peripheral cocaine receptors. J Pharmacol Exp Ther 243:61-68
8. 3H]cocaine in striatum and its relationship to the dopamine transporter. Membr Biochem 7:87-106
9. Carroll FI, Lewin AH, Boja JW, Kuhar MJ (1992) Cocaine receptor: biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter. J Med Chem 35:969-981
10. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108
11. 3H]WIN 35,428 binding to the dopamine uptake carrier. I. Effect of tonicity and buffer composition. J Neurosci Methods 51:23-30
12. DeLean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97-102
13. 3H]GBR 12935 to rat and bovine striata. Membr Biochem 10:129-144
14. 3H]sulpiride binding sites in rat striatal membranes. J Neurochem 38:1459-1465
15. Giros B, Caron MG (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14:43-49
16. Giros B, Wang YM, Suter S, McLeskey SB, Pifl C, Caron MG (1994) Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J Biol Chem 269:15985-15988
17. Goeders NE, Smith JE (1986) Reinforcing properties of cocaine in the medical prefrontal cortex: primary action on presynaptic dopaminergic terminals. Pharmacol Biochem Behav 25:191-199
18. Heron C, Costentin J, Bonnet JJ (1994) Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier. Eur J Pharmacol 264:391-398
19. 3H]mazindol binding sites from alkylation by N-ethylmaleimide. Eur J Pharmacol 227:411-415
20. 3H]mazindol binding sites from alkylation by N-ethylmaleimide. Eur J Pharmacol 227:411-415
21. Jones SR, Garris PA, Kilts CD, Wightman RM (1995) Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudateputamen, and nucleus accumbens of the rat. J Neurochem 64:2581-2589
22. Kennedy LT, Hanbauer I (1983) Sodium-sensitive cocaine binding to rat striatal membrane: possible relationship to dopamine uptake sites. J Neurochem 41:172-178
23. Kirifides AL, Harvey JA, Aloyo VJ (1992) The low affinity binding site for the cocaine analog, WIN 35,428 is an artifact of freezing caudate tissue. Life Sci 50:PL139-42
24. Kitayama S, Shimada S, Xu H, Markham L, Donovan DM, Uhl GR (1992) Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc Natl Acad Sci USA 89:7782-7785
25. + transport. Synapse 15:58-62
26. Krueger BK (1990) Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus. J Neurochem 55:260-267
27. Kuhar MJ, Ritz MC, Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
29. 3H]cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251:131-141
30. May LJ, Kuhr WG, Wightman RM (1988) Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry. J Neurochem 51:1060-1069
31. McElvain JS, Schenk JO (1992) A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine. Biochem Pharmacol 43:2189-2199
32. Meiergerd SM, Schenk JO (1994) Striatal transporter for dopamine: catechol structure-activity studies and susceptibility to chemical modification. J Neurochem 62:998-1008
33. 3H]GBR 12,935 binding. Mol Pharmacol 45:125-135
34. Reith MEA (1988) Cocaine receptors on monoamine transporters and sodium channels. NIDA Res Monogr 88:23-43
35. 3H]tropane to the dopamine uptake carrier. J Neurochem 61:167-177
36. 3H]WIN 35,428 binding to the dopamine uptake carrier. II. Effect of membrane fractionation procedure and freezing. J Neurosci Methods 51:31-38
37. Reith MEA, Selmeci G (1992) Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935. Naunyn Schmiedeberg's Arch Pharmacol 345:309-318
38. Reith MEA, Meisler BE, Sershen H, Lajtha A (1986a) Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem Pharmacol 35:1123-1129
39. 3H]cocaine in mouse striatum and cerebral cortex have different dissociation kinetics. J Neurochem 46:309-312
40. Reith MEA, de Costa B, Rice KC, Jacobson AE (1992) Evidence for mutually exclusive binding of cocaine, BTCP, GBR 12935, and dopamine to the dopamine transporter. Eur J Pharmacol 227:417-425
41. 3H] WIN 35,428) binding. Biochem Pharmacol 52:1435-1446
42. Richelson E, Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104:277-286
43. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223
44. Roberts DC, Koob GF, Klonoff P, Fibiger HC (1980) Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol Biochem Behav 12:781-787
45. Rothman RB (1990) High affinity dopamine reuptake inhibitors as potential cocaine antagonists: a strategy for drug development. Life Sci 46:PL17-21
46. Rothman RB, Mele A, Reid AA, Akunne H, Greig N, Thurkauf A, Rice KC, Pert A (1989) Tight binding dopamine reuptake inhibitors as cocaine antagonists. A strategy for drug development [published erratum appears in FEBS Lett 1990 Jan 15;260:152]. FEBS Lett 257:341-344
47. 3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonists. Life Sci 53:PL267-72
48. 125I]RTI-55. J Pharmacol Exp Ther 270:296-309
49. Saadouni S, Refahi-Lyamani F, Costentin J, Bonnet JJ (1994) Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier. Eur J Pharmacol 268:187-197
50. 3H]threo-(±)-methylphenidate to the stimulant recognition site. Neuropharmacology 29:901-908
51. Shank RP, Gardocki JF, Schneider CR, Vaught JL, Setler PE, Maryanoff BE, McComsey DF (1987) Preclinical evaluation of McN-5707 as a potential antidepressant. J Pharmacol Exp Ther 242:74-84
52. Smith RP, Ellman GL (1973) A study of the dependence of the human erythrocyte glucose transport system on membrane sulfhydryl groups. J Membr Biol 12:177-188
53. Uhl GR, Johnson PS (1994) Neurotransmitter transporters: three important gene families for neuronal function. J Exp Biol 196:229-236
54. 125I]iodophenyl)tropane binding. Mol Pharmacol 43:264-270
55. Wang J, Davis S, Uhl GR (1993) Dopamine transporter site-directed mutants identify residues selectively important for cocaine recogition. Soc Neurosci Abstr 19:745
56. Wang JB, Moriwaki A, Uhl GR (1995) Dopamine transporter cysteine mutants: second extracellular loop cysteines are required for transporter expression. J Neurochem 64:1416-1419
57. Wheeler DD, Edwards AM, Chapman BM, Ondo JG (1994) Effects of cocaine on sodium dependent dopamine uptake in rat striatal synaptosomes. Neurochem Res 19:49-56
58. Wise RW (1984) Neural mechanism of the reinforcing action of cocaine. In: Grabowski J (ed) Cocaine: pharmacology, effects and treatment of abuse, NIDA Res Monogr 50:15-33
59. Woolverton WL, Johnson KM (1992) Neurobiology of cocaine abuse. Trends Pharmacol Sci 13:193-200
60. Xu C, Coffey LL, Reith MEA (1995) Translocation of dopamine and binding of 2β-carbomethoxy-3β-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers. Biochem Pharmacol 49:339-350
61. Zimanyi I, Lajtha A, Reith MEA (1989) Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum. Naunyn Schmiedeberg's Arch Pharmacol 340:626-632